An expansion in access to mifepristone for telehealth patients is at risk before the Supreme Court. What does this mean for the FDA approvals process?

The FDA has issued a Class I recall for Vyaire Medical respiratory support devices, saying use of older, defective devices could result in injury or death.

More than 5,000 U.S. physicians joined forces to launch the new group. They say they are focused on limiting private equity's involvement and influence in healthcare. 

“Given the unprecedented magnitude of this cyberattack, and in the best interest of patients and health care providers, OCR is initiating an investigation into this incident,” states a “Dear Colleague” letter from OCR director Melanie Fontes Rainer.

"[S]ome states, including—until recently—Texas, even employ an honor-system approach, which relies on physicians to self-report. But guess what? The bad doctors tend not to do that, because they’re bad doctors."

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

“This is what happens when everything merges and you only have one option.”

A joint announcement from the DOJ, FTC and HHS asks for providers, patients or other industry experts to share their experiences with private equity transactions, including those not typically subject to antitrust review by law.